CPL Associates   Report issue

For profit Phase 4
Founded: Buffalo NY United States (1975)
Status: No NME R&D (1975)

Organization Overview

First Clinical Trial
2002
NCT00358202
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

CPL Associates, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bronchitis (Phase 4)

Bronchitis, Chronic (Phase 4)

Communicable Diseases (Phase 4)

Infections (Phase 4)

Maxillary Sinusitis (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Bacterial (Phase 4)

Respiratory Tract Infections (Phase 4)

Sinusitis (Phase 4)

Staphylococcal Infections (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6